Effect of Rosiglitazone on Peritoneal Cytokines in Women With Endometriosis
Status:
Withdrawn
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of rosiglitazone versus placebo on soluble
proinflammatory markers in peritoneal fluid of women with endometriosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)